Vimarsana
Biggest News Aggregation in the World

Page 4 - Frederic Chereau News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Frederic Chereau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Frederic Chereau Today - Breaking & Trending Today

LogicBio Therapeutics to Participate in Upcoming Investor Conferences - Vimarsana News

LogicBio Therapeutics to Participate in Upcoming Investor Conferences

/PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to...

Around the house: former GC for The New Yorker moves to Ballard Spahr - Vimarsana News

Around the house: former GC for The New Yorker moves to Ballard Spahr

Around the house: former GC for The New Yorker moves to Ballard Spahr 13 May 2021 Around the house: former GC for The New Yorker moves to Ballard Spahr This week's round of in-house appointments also sees ride-hailing giant Grab name a Skadden partner GC as it gears up for a record-setting SPAC merger Former  First Look Media GC joins Ballard Spahr  Noted First Amendment attorney Lynn Oberlander, whose CV includes the GC spot at The New Yorker and First Look Media, has begun a role as of counsel in the New York office of Am Law 100 firm Ballard Spahr.  Oberlander has join...

LogicBio Therapeutics Strengthens Management Team with Key Appointments - Vimarsana News

LogicBio Therapeutics Strengthens Management Team with Key Appointments

LogicBio Therapeutics Strengthens Management Team with Key Appointments - New leadership includes Andrea Paul as general counsel and corporate secretary, and Janice Olson as senior vice president, strategy and portfolio management, bringing extensive experience in gene therapy and rare disease News provided by Share this article Share this article LEXINGTON, Mass., May 10, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulth...

LogicBio announces clinical and corporate updates - Vimarsana News

LogicBio announces clinical and corporate updates

LogicBio announces clinical and corporate updates DJ LogicBio announces clinical and corporate updates Arix Bioscience PLC (ARIX) LogicBio announces clinical and corporate updates 27-Apr-2021 / 14:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- Arix Bioscience plc LogicBio announces clinical and corporate updates - First patient in Phase I/II SUNRISE trial expected...

LogicBio Therapeutics Announces Clinical and Corporate Updates - Vimarsana News

LogicBio Therapeutics Announces Clinical and Corporate Updates

LogicBio Therapeutics Announces Clinical and Corporate Updates - First patient for Phase I/II SUNRISE trial expected to be enrolled by mid-year 2021 - Company also entered into strategic collaboration with CANbridge Pharmaceuticals and research partnership with Daiichi Sankyo News provided by Share this article Share this article LEXINGTON, Mass., April 27, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today annou...